Search Results - Tim Hagenacker

Refine Results
  1. 1

    Neuromuscular disorder as initial manifestation of secondary hyperparathyroidism – a case report by Karim Hajjar, Tim Hagenacker

    Published in European Journal of Translational Myology (2017-03-01)
    Get full text
    Article


  2. 2

    Gene replacement therapy in spinal muscular atrophy: filling the data gaps by Tim Hagenacker, Ulrike Schara-Schmidt

    Published in The Lancet Regional Health. Europe (2024-02-01)
    Get full text
    Article


  3. 3

    Editorial: Spinal Muscular Atrophy: Evolutions and Revolutions of Modern Therapy by Richard S. Finkel, Ulrike Schara-Schmidt, Tim Hagenacker

    Published in Frontiers in Neurology (2020-07-01)
    Get full text
    Article


  4. 4

    Diagnosing cardiac amyloidosis in every-day practice: A practical guide for the cardiologist by Maria Papathanasiou, Alexander Carpinteiro, Christoph Rischpler, Tim Hagenacker, Tienush Rassaf, Peter Luedike

    Get full text
    Article


  5. 5

    Induction of Survival of Motor Neuron (SMN) Protein Deficiency in Spinal Astrocytes by Small Interfering RNA as an In Vitro Model of Spinal Muscular Atrophy by Markus Leo, Linda-Isabell Schmitt, Michael Fleischer, Rebecca Steffen, Cora Osswald, Christoph Kleinschnitz, Tim Hagenacker

    Published in Cells (2022-02-01)
    Get full text
    Article


  6. 6

    Effectiveness of Nusinersen in Adolescents and Adults with Spinal Muscular Atrophy: Systematic Review and Meta-analysis by Tim Hagenacker, Lorenzo Maggi, Giorgia Coratti, Bora Youn, Stephanie Raynaud, Angela D. Paradis, Eugenio Mercuri

    Published in Neurology and Therapy (2024-09-01)
    Get full text
    Article


  7. 7

    Short Latency Gray Matter Changes in Voxel-Based Morphometry following High Frequent Visual Stimulation by Steffen Naegel, Tim Hagenacker, Nina Theysohn, Hans-Christoph Diener, Zaza Katsarava, Mark Obermann, Dagny Holle

    Published in Neural Plasticity (2017-01-01)
    Get full text
    Article


  8. 8

    Assessment of Bulbar Function in Adult Patients with 5q-SMA Type 2 and 3 under Treatment with Nusinersen by Svenja Brakemeier, Benjamin Stolte, Andreas Thimm, Kathrin Kizina, Andreas Totzeck, Juan Munoz-Rosales, Christoph Kleinschnitz, Tim Hagenacker

    Published in Brain Sciences (2021-09-01)
    Get full text
    Article


  9. 9

    Fungal Gut Microbiome in Myasthenia Gravis: A Sub-Analysis of the MYBIOM Study by Hedda Luise Verhasselt, Elakiya Ramakrishnan, Melina Schlag, Julian R Marchesi, Jan Buer, Christoph Kleinschnitz, Tim Hagenacker, Andreas Totzeck

    Published in Journal of Fungi (2023-05-01)
    Get full text
    Article


  10. 10

    Neuronal Pentraxin 2 as a Potential Biomarker for Nusinersen Therapy Response in Adults with Spinal Muscular Atrophy: A Pilot Study by Svenja Neuhoff, Linda-Isabell Schmitt, Kai Christine Liebig, Stefanie Hezel, Nick Isana Tilahun, Christoph Kleinschnitz, Markus Leo, Tim Hagenacker

    Published in Biomedicines (2025-07-01)
    Get full text
    Article


  11. 11

    Oral functions in adult persons with spinal muscular atrophy compared to a healthy control group: a prospective cross-sectional study with a multimodal approach by Teresa Kruse, Diana Leflerovà, Annette Cap, Sara Portegys, Brunhilde Wirth, Raoul Heller, Svenja Brakemeier, Tim Hagenacker, Bert Braumann, Gilbert Wunderlich

    Published in Orphanet Journal of Rare Diseases (2024-10-01)
    Get full text
    Article


  12. 12

    Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review by Maria Papathanasiou, Alexander Carpinteiro, David Kersting, Aiste‐Monika Jakstaite, Tim Hagenacker, Thomas‐Wilfried Schlosser, Christoph Rischpler, Tienush Rassaf, Peter Luedike

    Published in Molecular Genetics & Genomic Medicine (2021-12-01)
    Get full text
    Article


  13. 13

    Essen transition model for neuromuscular diseases by Michael Fleischer, Bayram Coskun, Benjamin Stolte, Adela Della-Marina, Heike Kölbel, Hildegard Lax, Michael Nonnemacher, Christoph Kleinschnitz, Ulrike Schara-Schmidt, Tim Hagenacker

    Published in Neurological Research and Practice (2022-09-01)
    Get full text
    Article


  14. 14

    Clinical Implication of Dosimetry of Computed Tomography- and Fluoroscopy-Guided Intrathecal Therapy With Nusinersen in Adult Patients With Spinal Muscular Atrophy by Kathrin Kizina, Benjamin Stolte, Andreas Totzeck, Saskia Bolz, Michael Fleischer, Christoph Mönninghoff, Nika Guberina, Denise Oldenburg, Michael Forsting, Christoph Kleinschnitz, Tim Hagenacker

    Published in Frontiers in Neurology (2019-11-01)
    Get full text
    Article


  15. 15

    Results of the preclinical multicenter randomized controlled paclitaxel-induced neuropathy prevention replication study (PINPRICS) by Wolfgang Boehmerle, Tim Hagenacker, Markus Leo, Linda-Isabell Schmitt, Helmar C. Lehmann, Ines Klein, Regina Stegherr, Frank Konietschke, Matthias Endres, Petra Huehnchen

    Published in BMC Research Notes (2025-04-01)
    Get full text
    Article


  16. 16

    Prediction of Recurrence and Rupture Risk of Ruptured and Unruptured Intracranial Aneurysms of the Posterior Circulation: A Machine Learning-Based Analysis by Martin Növer, Hanna Styczen, Ramazan Jabbarli, Philipp Dammann, Martin Köhrmann, Tim Hagenacker, Christoph Moenninghoff, Michael Forsting, Yan Li, Isabel Wanke, Aydin Demircioğlu, Cornelius Deuschl

    Published in Diagnostics (2025-09-01)
    Get full text
    Article


  17. 17

    Analysis of Free Circulating Messenger Ribonucleic Acids in Serum Samples from Late-Onset Spinal Muscular Atrophy Patients Using nCounter NanoString Technology by Markus Leo, Linda-Isabell Schmitt, Fabian Mairinger, Andreas Roos, Christina Hansmann, Stefanie Hezel, Jelena Skuljec, Refik Pul, Ulrike Schara-Schmidt, Christoph Kleinschnitz, Tim Hagenacker

    Published in Cells (2023-09-01)
    Get full text
    Article


  18. 18

    A Sum Score to Define Therapy-Refractory Myasthenia Gravis: A German Consensus by Michael Schroeter, Benjamin Berger, Franz Blaes, Tim Hagenacker, Sebastian Jander, Julia Kaiser, Petra Kalischewski, De-Hyung Lee, Tobias Ruck, Ulrike Schara, Peter Urban, Andreas Meisel

    Published in Journal of Central Nervous System Disease (2021-02-01)
    Get full text
    Article


  19. 19

    Triiodothyronine treatment in mice improves stroke outcome and reduces blood–brain barrier damage by Daniel Ullrich, Dagmar Führer, Heike Heuer, Steffen Mayerl, Steffen Haupeltshofer, Linda-Isabell Schmitt, Markus Leo, Rebecca D Szepanowski, Tim Hagenacker, Markus Schwaninger, Christoph Kleinschnitz, Friederike Langhauser

    Published in European Thyroid Journal (2025-02-01)
    Get full text
    Article


  20. 20

    Correction to: Short-term safety results from compassionate use of risdiplam in patients with spinal muscular atrophy in Germany by Andreas Hahn, René Günther, Albert Ludolph, Oliver Schwartz, Regina Trollmann, Patrick Weydt, Markus Weiler, Kathrin Neuland, Martin Sebastian Schwaderer, Tim Hagenacker, the Risdiplam Compassionate Use Program Group

    Published in Orphanet Journal of Rare Diseases (2022-10-01)
    Get full text
    Article


Search Tools: